iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
3.910
-0.110 (-2.74%)
At close: Apr 1, 2025, 4:00 PM
3.881
-0.029 (-0.74%)
After-hours: Apr 1, 2025, 5:02 PM EDT

iBio, Inc. Market Cap

iBio, Inc. has a market cap or net worth of $38.61 million as of April 1, 2025. Its market cap has increased by 865.25% in one year.

Market Cap
38.61M
Enterprise Value
35.95M
1-Year Change
865.25%
Ranking
Category
Stock Price
$3.91

Market Cap Chart

Since November 16, 2009, iBio, Inc.'s market cap has increased from $27.70M to $38.61M, an increase of 39.39%. That is a compound annual growth rate of 2.18%.

History

DateMarket Cap% Change
Mar 31, 202539.70M77.23%
Dec 31, 202422.40M1,078.95%
Dec 29, 20231.90M-52.50%
Dec 30, 20224.00M-96.66%
Dec 31, 2021119.70M-37.40%
Dec 31, 2020191.20M2,320.25%
Dec 31, 20197.90M-43.57%
Dec 31, 201814.00M-14.63%
Dec 29, 201716.40M-53.41%
Dec 30, 201635.20M-18.71%
Dec 31, 201543.30M-12.17%
Dec 31, 201449.30M128.24%
Dec 31, 201321.60M-27.03%
Dec 31, 201229.60M10.04%
Dec 30, 201126.90M-73.23%
Dec 31, 2010100.50M298.81%
Dec 31, 200925.20M-9.03%
View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 741.66B
UnitedHealth Group 479.08B
Johnson & Johnson 399.65B
AbbVie 370.64B
Novo Nordisk 302.16B
Abbott Laboratories 230.06B
Merck & Co. 226.74B
AstraZeneca 225.46B
Market Cap Rankings